CLC acquired by Diazyme Laboratories
Diazyme announces acquisition of Carolina Liquid Chemistries Corporation, an FDA registered manufacturer of chemistry systems and reagents.
See the latest news and media coverage for CLC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of clinical diagnostic analyzers, reagents, and laboratory services
carolinachemistries.comLast updated
In short: CLC was acquired by Diazyme Laboratories, which announced the deal after recent product and industry milestones.
Diazyme announces acquisition of Carolina Liquid Chemistries Corporation, an FDA registered manufacturer of chemistry systems and reagents.
Laboratories with moderate complexity licensure can now perform the test on Abbott ImmTox™ 270. It quantifies ethyl alcohol in urine, serum, or plasma for healthcare settings.
The FDA-cleared point-of-care test detects fentanyl in urine at 1.0 ng/mL cutoff in under six minutes on RYAN analyzer.
It partners with Kamiya for CLIA moderate complexity categorization. The reagent measures urine albumin to aid kidney dysfunction diagnosis.
Diazyme Laboratories, Inc. has acquired the business of Carolina Liquid Chemistries Corporation (CLC). CLC is an FDA-registered manufacturer and value-added reseller of chemistry systems and...
Diazyme Laboratories, Inc. announced today that it has acquired the business of Carolina Liquid Chemistries Corporation (CLC). CLC is an FDA registered ...
An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988...
GREENSBORO, N.C., Oct. 12, 2021 /PRNewswire/ -- Carolina Liquid Chemistries Corp. (CLC) announces it has received certification as a Veteran-Owned Small Business (VOSB) and been...
Track CLC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CLC and other trending companies.